Table 5.
Transfusion and mortality.
| ALL | Combined group | Discharged | ||||||
|---|---|---|---|---|---|---|---|---|
| Death | Discharged | p value | ALL | MNF NEC | SNF NEC | p value | ||
| N = 321 | N = 85 | N = 236 | N = 236 | N = 114 | N = 122 | |||
| Platelet tx before NEC | n = 225 | n = 62 | n = 163 | n = 163 | n = 51 | n = 112 | ||
| Platelet tx before NEC | 0.09 | 0.832 | ||||||
| 0 | 191 (84.9%) | 47 (75.8%) | 144 (88.3%) | 144 (88.3%) | 44 (86.3%) | 100 (89.3%) | ||
| 1 | 17 (7.56%) | 7 (11.3%) | 10 (6.13%) | 10 (6.13%) | 4 (7.84%) | 6 (5.36%) | ||
| 2 | 8 (3.56%) | 4 (6.45%) | 4 (2.45%) | 4 (2.45%) | 1 (1.96%) | 3 (2.68%) | ||
| 3+ | 9 (4.00%) | 4 (6.45%) | 5 (3.07%) | 5 (3.07%) | 2 (3.92%) | 3 (2.68%) | ||
| Total yes | 34 (15.1%) | 15 (24.2%) | 19 (11.7%) | 19 (11.7%) | 7 (13.7%) | 12 (10.7%) | ||
| Platelet tx 48 h after NEC | n = 225 | n = 63 | n = 162 | n = 162 | n = 47 | n = 115 | ||
| Platelet tx 48 h after NEC | 0.99 | <0.001 | ||||||
| 0 | 148 (65.8%) | 42 (66.7%) | 106 (65.4%) | 106 (65.4%) | 43 (91.5%) | 63 (54.8%) | ||
| 1 | 46 (20.4%) | 13 (20.6%) | 33 (20.4%) | 33 (20.4%) | 3 (6.38%) | 30 (26.1%) | ||
| 2 | 17 (7.56%) | 4 (6.35%) | 13 (8.02%) | 13 (8.02%) | 1 (2.13%) | 12 (10.4%) | ||
| 3+ | 14 (6.22%) | 4 (6.35%) | 10 (6.17%) | 10 (6.17%) | 0 (0.00%) | 10 (8.70%) | ||
| Total yes | 77 (34.2%) | 21 (33.3%) | 56 (34.6%) | 56 (34.6%) | 4 (8.51%) | 52 (45.2%) | ||
| Blood tx before NEC | n = 282 | n = 73 | n = 209 | n = 209 | n = 100 | n = 109 | ||
| Blood tx before NEC | 0.823 | 0.036 | ||||||
| 0 | 147 (52.1%) | 35 (47.9%) | 112 (53.6%) | 112 (53.6%) | 56 (56.0%) | 56 (51.4%) | ||
| 1 | 27 (9.57%) | 8 (11.0%) | 19 (9.09%) | 19 (9.09%) | 9 (9.00%) | 10 (9.17%) | ||
| 2 | 32 (11.3%) | 8 (11.0%) | 24 (11.5%) | 24 (11.5%) | 5 (5.00%) | 19 (17.4%) | ||
| 3+ | 76 (27.0%) | 22 (30.1%) | 54 (25.8%) | 54 (25.8%) | 30 (30.0%) | 24 (22.0%) | ||
| Total yes | 135 (47.9%) | 38 (52.1%) | 97 (46.4%) | 97 (46.4%) | 44 (44.0%) | 53 (48.6%) | ||
| Blood tx before NEC | n = 267 | n = 73 | n = 194 | n = 194 | n = 91 | n = 103 | ||
| Blood tx 48 h after NEC | 0.003 | <0.001 | ||||||
| 0 | 108 (40.4%) | 17 (23.3%) | 91 (46.9%) | 91 (46.9%) | 66 (72.5%) | 25 (24.3%) | ||
| 1 | 89 (33.3%) | 28 (38.4%) | 61 (31.4%) | 61 (31.4%) | 22 (24.2%) | 39 (37.9%) | ||
| 2 | 37 (13.9%) | 16 (21.9%) | 21 (10.8%) | 21 (10.8%) | 2 (2.20%) | 19 (18.4%) | ||
| 3+ | 33 (12.4%) | 12 (16.4%) | 21 (10.8%) | 21 (10.8%) | 1 (1.10%) | 20 (19.4%) | ||
| Total yes | 159 (59.6%) | 56 (76.7%) | 103 (53.1%) | 103 (53.1%) | 25 (27.5%) | 78 (75.7%) | ||
Cells are represented as n (%), differences in categorical measures were tested using a chi-square test or Fisher’s exact test.
MNF medical non-fulminant NEC, SNF surgical non-fulminant NEC.